Institution
Azienda sanitaria universitaria Giuliano Isontina
Also known as: ASU GI · ASUGI
- 74running trials
- 23closed trials
- 2,346publications (OpenAlex)
Running trials
Recruiting
Recruiting
Not yet recruiting
Recruiting
Clinical Trial of NS-863 in Participants With Pulmonary Arterial Hypertension (PAH)
Recruiting
Not yet recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Study to Evaluate Soquelitinib in Participants With Moderate to Severe AD
Recruiting
A Study to Assess the Effectiveness and Safety of GSK3862995B in Adults With Bronchiectasis
Recruiting
Recruiting
Transcranial Alternating Current Stimulation in Lewy Body Dementia
Recruiting
Recruiting
Recruiting
A Study to Assess the Efficacy and Safety of Empasiprubart in Adults With CIDP
Recruiting
Recruiting
Recruiting
A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
Recruiting
Recruiting
A Study of Pirtobrutinib in Participants With Immune Thrombocytopenia
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
Recruiting
Not yet recruiting
Palmitoylethanolamide and Luteolin in Patients with Acute Ischemic Stroke
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Recruiting
A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Patients
Recruiting
MYTHS-MR Trial (MYocarditis THerapy With Steroids in Patients With Mildly Reduced Ejection Fraction)
Recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Recruiting
Ibrutinib for the Treatment of AIHA in Patients With CLL/SLL or CLL-like MBL
Active, not recruiting
Recruiting
Tranexamic acid for hyperacute spontaneous IntraCerebral Haemorrhage (TICH-3)
Recruiting
Active, not recruiting
Active, not recruiting
Study of Atezolizumab Plus BEGEV Regimen in Relapsed or Refractory Hodgkin's Lymphoma Patients
Active, not recruiting
Showing 50 of 74.
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Immune thrombocytopenia (ITP)6 recruiting
- Acute myeloid leukaemia3 recruiting
- Chronic lymphocytic leukaemia3 recruiting
- High blood pressure3 recruiting
- Amyloidosis2 recruiting
- Bronchiectasis2 recruiting
- Dilated cardiomyopathy2 recruiting
- Follicular lymphoma2 recruiting
- Heart failure2 recruiting
- IgA nephropathy2 recruiting
- Mantle cell lymphoma2 recruiting
- Mesothelioma2 recruiting
- Prostate cancer2 recruiting
- Pulmonary arterial hypertension2 recruiting
- Stroke2 recruiting
- Alzheimer disease1 recruiting
- Asthma1 recruiting
- Atopic dermatitis (eczema)1 recruiting
- Chronic kidney disease1 recruiting
- CIDP (chronic inflammatory demyelinating polyneuropathy)1 recruiting
- Cystic fibrosis1 recruiting
- Epilepsy1 recruiting
- Fabry disease1 recruiting
- Hodgkin lymphoma1 recruiting
- Hypertrophic cardiomyopathy1 recruiting
- Lewy body dementia1 recruiting
- Lung cancer1 recruiting
- Macular degeneration1 recruiting
- Myocarditis1 recruiting
- Type 2 diabetes1 recruiting
Closed trials
Withdrawn
Completed
Withdrawn
Completed
Efficacy and Safety of Seralutinib in Adult Subjects With PAH (PROSERA)
Active, not recruiting
Completed
An Open-label Study of Povetacicept in Participants With Autoimmune Cytopenias (RUBY-4)
Completed
Completed
Completed
Safety and Tolerability of AC01 in patients with heart failure
Active, not recruiting
Completed
Completed
Efficacy and Safety of Intravenous Efzofitimod in Patients With Pulmonary Sarcoidosis
Completed
Completed
Completed
Completed
Recruiting
Prephase Treatment With Prednisone +/- Vitamin D Supplementation Followed by Immunochemotherapy
Completed
Completed
Completed
A Study of TAK-079 in Adults With Persistent/Chronic Primary Immune Thrombocytopenia
Completed
Active, not recruiting
Brentuximab Vedotin Plus Lenalidomide and Rituximab for the Treatment of Relapsed/Refractory DLBCL
Completed
Registry name variants (13)
Trial registries list this institution under these names. Each row is one registry entry: its address and the trials registered under it.
Azienda Sanitaria Universitaria Giuliano Isontina
Trieste, 34128
87 trials
Azienda Sanitaria Universitaria Giuliano Isontina (ASUGI)
Trieste, 34149
3 trials
Contact: Gianfranco SInagra
NCT04278924A Study of TAK-079 in Adults With Persistent/Chronic Primary Immune Thrombocytopenia
NCT04600804The Role of 18F-FDG-PET for Staging and Prognostication
Azienda Sanitaria Universitaria Giuliano Isontina (ASUGI) - SC Ematologia
Trieste, 34121
2 trials
Azienda Sanitaria Universitaria Giuliano Isontina (ASU GI)
Trieste, 34149
1 trial
Contact: Carlo Trombetta, MD
Azienda Sanitaria Universitaria Giuliano Isontina di Trieste
Trieste, TS 34139
1 trial
NCT07375771Transcranial Alternating Current Stimulation in Lewy Body Dementia
Contact: Alberto Benussi, MD
Azienda Sanitaria Universitaria Giuliano Isontina
Trieste, 34128
1 trial
Azienda Sanitaria Universitaria Giuliano Isontina - Trieste
Trieste, 34128
1 trial
Center for Diagnosis and Treatment of Cardiomyopathies, Cardiovascular Department, Azienda Sanitaria Universitaria Giuliano-Isontina (ASUGI), University of Trieste
Trieste, 34100
1 trial
Contact: Marco Merlo, Prof. Dr.
Azienda Sanitaria Universitaria Giuliano Isontina
Venezia, Giulia 34149
Azienda Sanitaria Universitaria Giuliano Isontina (Asugi) di Trieste
Trieste, TS 34148
Azienda Sanitaria Universitaria Giuliano Isontina (ASUGI) (Site 2405)
Trieste, Friuli Venezia Giulia 34149
SC Ematologia - Azienda Sanitaria Universitaria Giuliano Isontina (ASUGI)
Trieste, 34121
Trieste - Azienda Sanitaria Universitaria Giuliano Isontina (ASUGI) - SC Ematologia
Trieste, 34121
Conditions
Diseases this institution publishes on or runs trials for.
- Amyloidosis30 works · 2 trials
- Dilated cardiomyopathy21 works · 2 trials
- Myocarditis21 works · 1 trial
- Hypertrophic cardiomyopathy17 works · 2 trials
- Ventricular tachycardia9 works · 0 trials
- Immune thrombocytopenia (ITP)9 works · 12 trials
- Fabry disease3 works · 1 trial
Institution data: ROR 0025bcv33 (CC0-1.0)Updated 15 Nov 2026